期刊文献+

微小RNA在复发性流产发病机制中的研究进展

Research progress of microRNA in the pathogenesis of recurrent miscarriage
下载PDF
导出
摘要 复发性流产是威胁女性身心健康的疑难病症之一,其临床诊断和治疗仍是生殖健康领域亟待解决的重大问题。微小RNA(miR)在细胞的增殖、迁移、侵袭、分化等方面具有重要的调节作用,已经成为很多领域的研究热点。miR可以参与复发性流产的发生与发展并且具有高度保守性,差异表达的miR可以作为临床诊断的潜在标志物。本文从胎盘滋养细胞、子宫蜕膜组织、母胎免疫微环境等多角度阐述miR在复发性流产发病机制中的研究进展,以期为复发性流产的诊断和治疗探索新的标志物。 Recurrent abortion is one of the difficult diseases that threaten women′s physical and mental health,and its clinical diagnosis and treatment are still major issues that need to be addressed in the field of reproductive health.MicroRNA(miR)plays an important regulatory role in cell proliferation,migration,invasion,differentiation,and other aspects,and has become a research hotspot in many fields.MiR can participate in the occurrence and development of recurrent abortion and is highly conserved.Differentially expressed miR can serve as potential biomarkers for clinical diagnosis.In this article,the research progress of miR in the pathogenesis of recurrent abortion was reviewed from the perspectives of placental trophoblasts,uterine decidua tissue,maternal fetal immune microenvironment,etc.,in order to explore new markers for the diagnosis and treatment of recurrent abortion.
作者 王丹 李一帆 王瑞琳 费冰 刘莹 任彦颖 王春霞 李雪冰 李永伟 Wang Dan;Li Yifan;Wang Ruilin;Fei Bing;Liu Ying;Ren Yanying;Wang Chunxia;Li Xuebing;Li Yongwei(Second Clinical Medical College,Henan University of Chinese Medicine,Zhengzhou 450002,China;Department of Clinical Laboratory,Henan Province Hospital of Traditional Chinese Medicine,the Second Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450002,China)
出处 《中国医药》 2023年第12期1916-1920,共5页 China Medicine
基金 河南省卫生健康委员会中医药拔尖人才项目(豫卫中医函[2021]15号)。
关键词 复发性流产 微小RNA 免疫微环境 蜕膜反应 Recurrent abortion MicroRNA Immune microenvironment Decidual reaction
  • 相关文献

二级参考文献37

  • 1曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004:2163-2169.
  • 2谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 3Practice Committee of the American Society for Reproductive Medicine.Evaluation and treatment of recurrent pregnancy loss:a committee opinion[J].Fertil Steril,2012,98(5):1103-1111.DOI:10.1016/j.fertnstert.2012.06.048.
  • 4Royal College of Obstetricians and Gynaecologists.The investigation and treatment of couples with recurrent first- trimester and second-trimester miscarriage (Green-top Guide- line No.17).April 2011[EB/OL].[2015-06-08].https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_17.pdf.
  • 5Salim R,Regan L,Woelfer B,et al.A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage[J].Hum Reprod,2003,18(1):162-166.D01:10.1093/humrep/ deg030.
  • 6Berghella V,Odibo AO,To MS,et al.Cerclage for short cervix on ultrasonography:meta-analysis of trials using individual patient-level data[J].Obstet Gynecol,2005,106(1):181-189.DOI:10.1097/01.AOG.0000168435.17200.53.
  • 7Drakeley AJ,Roberts D,Alfirevic Z.Cervical cerclage for prevention of preterm delivery:meta-analysis of randomized trials[J].Obstet Gynecol,2003,102(3):621-627.DOI:10.1016/ s0029-7844(03)00673-2.
  • 8Kovalevsky G,Gracia CR,Berlin JA,et al.Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss:a meta-analysis[J].Arch Intern Med,2004,164(5):558-563.D01:10.1001/archinte.l64.5.558.
  • 9Onderoglu L,Baykal C,Al RA,et al.High frequency of thrombophilic disorders in women with recurrent fetal miscarriage[J].Clin Exp Obstet Gynecol,2006,33(1):50-54.
  • 10Loew A,Jacob D,Neuhaus P,et al.Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation[J].Transplantation,2005,79(10):1422-1427.DOI:10.1097/01.TP.0000158021.66004.19.

共引文献594

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部